Antiviral response and immunopathogenesis of interleukin 27 in COVID-19
Archives of Virology · 2023-07 · 168 (7)
DOI: 10.1007/s00705-023-05792-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Virology, online erschienen am 13.06.2023. Verfasst von Juan Felipe Valdés-López und 1 weiteren Autor:innen. Beteiligte Einrichtung: Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia. Hauptthemen laut MEDLINE: COVID-19, Interleukin-27. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Antioquia.
Abstract (Originalsprache)
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with a high mortality rate. The clinical course is attributed to the severity of pneumonia and systemic complications. In COVID-19 patients and murine models of SARS-CoV-2 infection, the disease may be accompanied by excessive production of cytokines, leading to an accumulation of immune cells in affected organs such as lungs. Previous reports have shown that SARS-CoV-2 infection antagonizes interferon (IFN)-dependent antiviral response, thereby preventing the expression of IFN-stimulated genes (ISGs). Lower IFN levels have been linked to more-severe COVID-19. Interleukin 27 (IL27) is a heterodimeric cytokine composed of IL27p28 and EBI3 subunits, which induce both pro- and anti-inflammatory responses. Recently, we and others have reported that IL27 also induces a strong antiviral response in an IFN-independent manner. Here, we investigated transcription levels of both IL27 subunits in COVID-19 patients. The results show that SARS-CoV-2 infection modulates TLR1/2-MyD88 signaling in PBMCs and monocytes and induces NF-κB activation and expression of NF-κB-target genes that are dependent on a robust pro-inflammatory response, including EBI3; and activates IRF1 signaling which induces IL27p28 mRNA expression. The results suggest that IL27 induces a robust STAT1-dependent pro-inflammatory and antiviral response in an IFN-independent manner in COVID-derived PBMCs and monocytes as a function of a severe clinical course of COVID-19. Similar results were observed in macrophages stimulated with the SARS-CoV-2 spike protein. Thus, IL27 can trigger an antiviral response in the host, suggesting the possibility of novel therapeutics against SARS-CoV-2 infection in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia.
- Grupo Inmunovirología, Facultad de Medicina, Universidad de Antioquia UdeA, Calle 70 No. 52-21, Medellín, Colombia. silvio.urcuqui@udea.edu.co.
Förderung
- University of Antioquia
Zitieren
APA
Valdés-López, J. F., & Urcuqui-Inchima, S. (2023). Antiviral response and immunopathogenesis of interleukin 27 in COVID-19. Archives of Virology, 168(7). https://doi.org/10.1007/s00705-023-05792-9
Vancouver
Valdés-López JF, Urcuqui-Inchima S. Antiviral response and immunopathogenesis of interleukin 27 in COVID-19. Archives of Virology. 2023;168(7). doi:10.1007/s00705-023-05792-9
BibTeX
@article{ValdsLpez2023,
author = {Valdés-López, Juan Felipe and Urcuqui-Inchima, Silvio},
title = {Antiviral response and immunopathogenesis of interleukin 27 in COVID-19},
journal = {Archives of Virology},
year = {2023},
volume = {168},
number = {7},
doi = {10.1007/s00705-023-05792-9}
}
EUVIMED